Adaptive Treatment Strategies for Improving Engagement With a Web-Based Smoking Intervention in Socially Anxious Smokers
Key facts
- Who runs it
- Fred Hutchinson Cancer Center
- Where
- Seattle, United StatesSee the site
- Trial code
- Status
- Withdrawn
- Phase
- Phase 1
- Started
- 15 Apr 2022
- Ended
- 31 Dec 2024
- Type of study
- Interventional, 2 groups
- Treatments tested
- Phase 1: Web-based intervention (MyWebQuit) with 1-way text messages
- Phase 1: Web-based intervention (MyWebQuit) with interactive, 2-way text messages
- Phase 2: re-engagement text messages
- Phase 2: re-engagement emails
- Record updated
- 8 December 2021
- Why it stopped
- PI departure
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 16 criteriaShow less
Who can take part
- resides in the US and anticipates remaining in the US for the duration of the study
- smokes at least 5 cigarettes per day for at least 12 months prior to screening
- desire to quit smoking within 30 days
- has at least weekly internet access
- current use of a personal email account
- current use of text messaging
- willing to receive text messages as part of this study
- screen positive for social anxiety (LSAS-SR ≥ 60)
- interested in participating in the study for themselves (versus [vs] someone else)
- not currently taking part in any other smoking cessation treatment such as the nicotine patch, nicotine gum, Zyban, in-person counseling, telephone counseling, using a web-based or app-based cessation program
- no prior participation in one of the investigator's prior smoking cessation studies,
- comfortable reading, writing, and speaking English
- agree to the conditions of compensation
- not currently incarcerated in a prison
- willing to use the MyWebQuit program, complete study assessments, and sign an online consent form
- no other member of their same household participating in the study
Where in United States
- Fred Hutch/University of Washington Cancer ConsortiumSeattle, United States
About the trial
What the trial wants to find out
This phase I trial will use a pilot sequential multiple assignment randomized trial (SMART) to examine protocol feasibility and acceptability of new components of a web-based intervention for socially anxious smokers. This study will be used to help build an adaptive treatment strategy to improve engagement with and effectiveness of the web-based intervention. Adaptive treatment strategies provide individualized sequences of intervention components to accommodate the changing needs of individuals based on their characteristics, treatment response, or engagement.
The 2 groups in the trial
- Phase 1Treatment being tested
Participants will be randomly assigned to one of the two text message programs that correspond with the web-based intervention (MyWebQuit): 1) standard, 1-way text messages, or 2) interactive, 2-way text messages
Treatment: Phase 1: Web-based intervention (MyWebQuit) with 1-way text messages and Phase 1: Web-based intervention (MyWebQuit) with interactive, 2-way text messages
- Phase 2Treatment being tested
For the first 5 weeks after randomization, engagement with the website will be monitored. Participants who continue to engage with the website will continue with the same Phase 1 treatment components until the 3-month follow-up. Participants who disengage with the website will be randomly assigned to receive one of three re-engagement strategies: 1) interactive, re-engagement text messages, 2) re-engagement email, or 3) no re-engagement strategy
Treatment: Phase 2: re-engagement text messages and Phase 2: re-engagement emails
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- A SMART Pilot of Adaptive Treatment Strategies to Improve Engagement With a Web-Based Intervention for Socially Anxious Smokers
- Record updated
- 8 December 2021